Dr. Laila Samiian, MD

Dr. Samiian practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Dr. Samiian's NPI, 1760663124, was assigned on November 14, 2007. Dr. Samiian graduated from University of Miami, Miller School of Medicine in 2000. Dr. Samiian holds Florida license ME 99569.

Dr. Samiian's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Dr. Samiian's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. Dr. Samiian is also affiliated with Baptist Medical Center Beaches. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Samiian to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samiian practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Samiian's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Samiian is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Samiian's licenses on file in 3 states: Florida, California and Michigan.

Dmand AI lists mastectomy among the conditions Dr. Samiian treats.

CMS data shows 236 Medicare services from Dr. Samiian across 9 procedure codes in 2024, for 103 Medicare patients. Medicare paid $48,740 for them.

CMS counts 103 Medicare patients who saw Dr. Samiian in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samiian's median patient age at 70, with 99% women.

In 2024, Dr. Samiian wrote 50 Medicare Part D claims for 31 patients. 100% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $719 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Samiian for performance year 2024, reported as part of a group. Dr. Samiian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of mastectomy by Dr. Samiian, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Samiian, published from 2016 to 2024. The most frequent topics are Breast Neoplasms, Florida and Triple Negative Breast Neoplasms. Dr. Samiian has published most often in Am Surg. Dr. Samiian's most frequent co-authors are Bharti Jasra, MD, Jennifer Ann Crozier, MD and Amanda Shreders Devereaux, MD.

Dmand AI links Dr. Samiian to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating.

CMS Open Payments shows 15 general payments to Dr. Samiian from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Merck Sharp & Dohme Corporation paid the most, $2,880.

Dmand AI lists 1 award for Dr. Samiian.

Dr. Samiian graduated from University of Miami, Miller School of Medicine in 2000. Dr. Samiian is a member of ACS, ASBS, ASCO, AAS and SSO.

Dr. Samiian is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.